Ab initio quantum mechanical study of the binding energies of human estrogen receptor α with its ligands: An application of fragment molecular orbital method
暂无分享,去创建一个
Kotoko Nakata | Tsuguchika Kaminuma | Masami Uebayasi | Tatsuya Nakano | Kaori Fukuzawa | Kazuo Kitaura | Kaori Fukuzawa | K. Kitaura | K. Nakata | T. Kaminuma | T. Nakano | M. Uebayasi
[1] Kaori Fukuzawa,et al. Fragment molecular orbital method: use of approximate electrostatic potential , 2002 .
[2] H Fang,et al. Quantitative comparisons of in vitro assays for estrogenic activities. , 2000, Environmental health perspectives.
[3] C. Glass,et al. The coregulator exchange in transcriptional functions of nuclear receptors. , 2000, Genes & development.
[4] Gerald T. Ankley,et al. The role of ligand flexibility in predicting biological activity: Structure–activity relationships for aryl hydrocarbon, estrogen, and androgen receptor binding affinity , 1998 .
[5] David A. Agard,et al. The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen , 1998, Cell.
[6] J. Gustafsson,et al. Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[7] J. Corton,et al. Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β. , 1998, Endocrinology.
[8] Gustavo E. Scuseria,et al. Linear Scaling Density Functional Calculations with Gaussian Orbitals , 1999 .
[9] J. Gustafsson,et al. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. , 1998, Molecular pharmacology.
[10] J. Gustafsson,et al. ERβ a Novel Estrogen Receptor Offers the Potential for New Drug Development , 1998, Trends in Endocrinology & Metabolism.
[11] Ching-Hsing Yu,et al. Ab Initio Geometry Determinations of Proteins. 1. Crambin , 1998 .
[12] K. Umesono,et al. The nuclear receptor superfamily: The second decade , 1995, Cell.
[13] Yuto Komeiji,et al. Fragment molecular orbital method: analytical energy gradients , 2001 .
[14] P B Sigler,et al. Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[15] Tudor I. Oprea,et al. Ligand-based identification of environmental estrogens. , 1996, Chemical research in toxicology.
[16] Fumitoshi Sato,et al. Calculation of all-electron wavefunction of hemoprotein cytochrome c by density functional theory , 2001 .
[17] Yutaka Akiyama,et al. Fragment molecular orbital method: application to polypeptides , 2000 .
[18] J. Pitera,et al. Simulations of the estrogen receptor ligand-binding domain: affinity of natural ligands and xenoestrogens. , 2000, Journal of medicinal chemistry.
[19] J. V. van Lier,et al. Quantitative structure-activity relationships/comparative molecular field analysis (QSAR/CoMFA) for receptor-binding properties of halogenated estradiol derivatives. , 1994, Journal of medicinal chemistry.
[20] B. Katzenellenbogen,et al. Different Residues of the Human Estrogen Receptor Are Involved in the Recognition of Structurally Diverse Estrogens and Antiestrogens* , 1997, The Journal of Biological Chemistry.
[21] Kaori Fukuzawa,et al. Fragment molecular orbital study of the binding energy of ligands to the estrogen receptor , 2003 .
[22] Masami Uebayasi,et al. Pair interaction molecular orbital method: an approximate computational method for molecular interactions , 1999 .
[23] K. Umesono,et al. A Unified Nomenclature System for the Nuclear Receptor Superfamily , 1999, Cell.
[24] K. Kitaura,et al. Fragment molecular orbital method: an approximate computational method for large molecules , 1999 .
[25] D. Moras,et al. Crystal Structure of a Mutant hERα Ligand-binding Domain Reveals Key Structural Features for the Mechanism of Partial Agonism* , 2001, The Journal of Biological Chemistry.
[26] M Carlquist,et al. Structure of the ligand‐binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist , 1999, The EMBO journal.
[27] D. Moras,et al. Structural studies on nuclear receptors , 2000, Cellular and Molecular Life Sciences CMLS.
[28] Kenichiro Tsuda,et al. Ab initio MO studies of interaction mechanisms of Protein Kinase C with cell membranes , 2001 .
[29] F. Sato,et al. An all-electron calculation of an antihypertensive protein with the Gaussian-based density functional method , 1999 .
[30] Marvin Waldman,et al. Application of structure‐based focusing to the estrogen receptor , 2001, J. Comput. Chem..
[31] Zbigniew Dauter,et al. Molecular basis of agonism and antagonism in the oestrogen receptor , 1997, Nature.
[32] M. Karplus,et al. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .
[33] Gerald T. Ankley,et al. Quantitative structure‐activity relationships for polychlorinated hydroxybiphenyl estrogen receptor binding affinity: An Assessment of conformer flexibility , 1996 .
[34] K. Grandien,et al. Printed in U.S.A. Copyright © 1997 by The Endocrine Society Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors � and � , 2022 .
[35] Eric Schwegler,et al. Linear scaling computation of the Fock matrix , 1997 .
[36] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[37] Carlos Sonnenschein,et al. An updated review of environmental estrogen and androgen mimics and antagonists , 1998, The Journal of Steroid Biochemistry and Molecular Biology.
[38] A. Steinmetz,et al. Binding of ligands and activation of transcription by nuclear receptors. , 2001, Annual review of biophysics and biomolecular structure.
[39] Roger Perkins,et al. QSAR Models for Binding of Estrogenic Compounds to Estrogen Receptor α and β Subtypes. , 1997, Endocrinology.